Information
- HOME>
- Information>
- Regarding the Launch of Overseas Sales for FLD HbA1c for Android
Regarding the Launch of Overseas Sales for FLD HbA1c for Android
2025.10.19
We commenced the domestic release of FLD HbA1c for Android via the SFM App Store in last September 2025.
We are pleased to announce that, as the first phase of out overseas expansion, we have decided to release FLD HbA1c for Android in seven countries across Southeast and Southwest Asia.
The subscription fee will be $100 per month (excluding tax).
The countries included in this release are as follows:
– Vietnam
– Thailand
– Cambodia
– Laos
– Indonesia
– Bangladesh
– Pakistan
The release date for in set to begin on October 22 ,2025
The compatible devices are the same as those in the Japanese release and are as follows:
Recommended devices include:
– Samsung Galaxy S23 series and later
– Google Pixel 7 series and later
Additionally, the application is compatible with Sony Xperia series (models released summer 2021 and later). While not recommended, it can also be used with the Samsung Galaxy S22 series.
Important and Disclaimer :Please note that our products are not medical devices. This application is a wellness app and cannot be used for diagnostics, treatment, or medical decision-making.
The measurements provided are for reference purposes only. If you have any health concerns, please consult a healthcare professional. Additionally, there are restrictions on compatible devices. Please ensure that your device is among the supported models, and review the applicable terms of use and privacy policy before using the app.